This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Vertex Pharmaceuticals’ CRISPR-based therapy made history as ...

A landmark trial has revealed that baricitinib, a pill already used to treat autoimmune diseases, can slow the progression of type 1 diabetes when given soon after diagnosis. Credit: Stock A 2-year ...

A man with type 1 diabetes produced his own insulin after receiving genetically edited donor cells, and he did it without taking drugs that shut down the immune system. Type 1 diabetes happens when ...

TL;DR: Polish developer Bloober Team is actively producing the Silent Hill 1 remake, leveraging their horror expertise and new "open cities" technology for future titles. The studio aims to shorten ...

TOLEDO, Ohio — General Motors (GM) is removing all of its electrical vehicle (EV) production technology from its Toledo Propulsions Systems facility on Alexis Road, according to UAW Local 14 President ...

China’s Ambassador to Nigeria, Yu Dunhai, disclosed plans by Chinese companies to establish a local insulin production facility in Nigeria. Yu said when completed, it would end Nigeria’s dependence on ...

Puratos is opening the first dedicated bakery glaze plant in the nation in late October in South Jersey. The new Ultra High Temperature facility in Camden County represents a significant development ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...